Banner
WHAT'S NEW
please select
#GO 2023 Medical Japan Tokyo Exclusive Interview(圖)
MEDIA
2023-11-03
GeneOnline had an exclusive interview with Taiwan’s 元樟生技 AMS BioteQ at the #2023_Medical_Japan_Tokyo.
AMS BioteQ Debuts in Medical Japan Tokyo 2023: Expanding into New Healthcare Markets(圖)
MEDIA
2023-10-25
Medical Japan Tokyo was held grandly from October 11 to 13, gathering medical professionals, manufacturers, medical institutions and research units from around the world. AMS BioteQ Co., Ltd. made its first appearance in the exhibition and became one of the spotlight.
Breaking Boundaries in Wound Care, AMS BioteQ at Medical Japan 2023(圖)
MEDIA
2023-10-03
AMS BioteQ: Pioneering Innovation in Antibiotics and Advanced Dressings
Since its establishment in 2018, AMS BioteQ, headquartered in Taiwan, has dedicated itself to the development of cutting-edge antibiotics and antimicrobial dressings.
Breaking Through the Dengue Fever Treatment(圖)
MEDIA
2023-10-03
Despite the ongoing prevalence of dengue fever in Taiwan, the primary method of epidemic prevention in our country still relies on traditional mosquito spray.
A New Star in Dengue Fever Treatment? AMS BioteQ Starts with Small Molecule Drugs(圖)
MEDIA
2023-08-09
AMS BioteQ collaborates with Professor Sheng-Fan Wang, Director of the Center for Tropical Medicine and Infectious Diseases Research at Kaohsiung Medical University
AMS BioteQ: A New Force in Taiwan's Fight Against Avian Influenza(圖)
MEDIA
2023-04-10
As the prices of eggs and chicken soar, avian influenza is posing a significant challenge to human society. The virus, which used to be limited to birds, has recently been reported to infect humans.
AMS BioteQ Officially Sets Foot in Kaohsiung Shi-Wei Financial Center!(圖)
NEWS
2023-03-02
We sincerely appreciate everyone’s long-term support and care for AMS BioteQ. On April 30, 2022, our company officially moved into the Kaohsiung Shi-Wei Financial Center. With a design layout brimming with modernity, we showcase our innovation and expertise, enhancing our overall service capability.
Another Breakthrough in Epidemic Prevention!(圖)
MEDIA
2021-12-10
Another Breakthrough in Epidemic Prevention! The Team at Kaohsiung Medical University Has Developed a COVID-19 Antibody Testing Platform for Precise Assessment of Antibody Efficacy
Yuanta Securities has been appointed as the recommended securities firm for AMS BioteQ Emerging Stock Board since Februa(圖)
NEWS
2023-03-02
Yuanta Securities has been appointed as the recommended securities firm for AMS BioteQ Emerging Stock Board since February 25, 2022!
Fighting the Global Superbug Crisis: AMS BioteQ Develops Taiwan's First Local Antibiotic(圖)
MEDIA
2021-11-25
AMS BioteQ Chairman, Dr. Yi-Ju Tsai (center), and the team are actively conducting research to develop potential new drugs and address the unmet topical medication market.
Antibiotic-Resistant Superbug – one of the greatest threats to human health.
AMS BioteQ Expands Patent Layout, Aims to Lead in New Antibiotic Drug Research(圖)
MEDIA
2021-11-19
AMS BioteQ focuses its research and development efforts on three key stages: “novel compound development,” “patent in research and development technology,” and “new drug research and development.”
New Force of Novel Antimicrobial Dressings! AMS BioteQ Benefits Diabetic Wound Patients(圖)
MEDIA
2021-09-15
Dressings play a crucial role in accelerating wound healing.